We have previously shown that Sp1-mediated transcription is stimulated by Rb and repressed by cyclin D1. The stimulation of Sp1 transcriptional activity by Rb is conferred, in part, through a direct interaction with the TBP-associated factor TAF II 250. Here we investigated the mechanism(s) through which cyclin D1 represses Sp1. We examined the ability of cyclin D1 to regulate transcription mediated by Gal4-Sp1 fusion proteins, which contain the Gal4 DNA-binding domain and Sp1 trans-activation domain(s). The domain of Sp1 sucient to confer repression by cyclin D1 was mapped to a region important for interaction with TAF II 110. We further demonstrate that TAF II 250-cyclin D1 complexes can be immunoprecipitated from mammalian and baculovirus-infected insect cells and that recombinant GST-TAF II 250 (amino acids 1 ± 434) associates with cyclin D1 in vitro. Moreover, the overexpression of Rb or CDK4 reduced the level of TAF II 250-cyclin D1 complex. The amino terminus of cyclin D1 (amino acids 1 ± 100) was sucient for association with TAF II 250 and for repressing Sp1-mediated transcription. Taken together, the results suggest that cyclin D1 may regulate transcription by interacting directly or indirectly with TAF II 250.
Introduction
The regulation of transcription is tightly linked to the regulation of the cell cycle, which is in turn mediated by cyclins and their associated cyclin-dependent kinases (Cross, 1995; Pines, 1995; Sherr, 1995) . In particular, the D-type cyclins, in association with CDK4 or CDK6, mediate the phosphorylation of the retinoblastoma tumor suppressor protein, Rb, resulting in the release of Rb-associated proteins such as the transcription factors E2F and Elf-1 Wang et al., 1993) . In addition, the cyclin H-CDK7 complex, also termed CAK for cyclin activating kinase, is associated with TFIIH and acts to phosphorylate the carboxy terminal domain (CTD) of the largest subunit of RNA polymerase II to initiate transcriptional elongation (Fisher et al., 1995; Fisher and Morgan, 1994; Makela et al., 1994) . Moreover, cyclin C and CDK8 were found to be associated with the RNA polymerase holoenzyme, but the targets for phosphorylation by CDK8 are unknown (Kuchin et al., 1995; Leopold and O'Farrell, 1991; Lew et al., 1991; Tassan et al., 1995) . Finally, cyclin A-cdk2 and cyclin E-cdk2 complexes are targeted to certain promoters with E2F sites through association with E2F-p107 and E2F-p130 complexes (Hijmans et al., 1995; Lees et al., 1992; Smith and Nevins, 1995; Vairo et al., 1995; Xu et al., 1994; Zhu et al., 1995a,b) .
In addition to regulating transcription through the phosphorylation of Rb, the D-type cyclins also appear able to regulate transcription directly. Cyclin D1 has been shown to repress both MyoD-mediated transcription and muscle dierentiation in part through a Rb independent mechanism (Gu et al., 1993; Skapek et al., 1996) . In addition, cyclin D is able to stimulate transcription mediated by the estrogen receptor through a direct association, independent of CDK4, suggesting that D1 may serve as a direct transcriptional regulator (Zwijsen et al., 1997; Neuman et al., 1997) . However, it is still unclear whether D1 stimulates binding of the estrogen receptor or if it is providing an additional function such as interacting with the basal transcriptional machinery when bound to the receptor. Interestingly, the D-type cyclins have homology with the basal transcription factor, TFIIB, suggesting that they may have a common origin. These results suggest that the D-type cyclins, in particular D1, are able to regulate transcription through multiple mechanisms that appear to be in part independent of an association with Rb or CDK4.
The transcription factor Sp1 contains two separate glutamine-rich domains, necessary for transcriptional activation. Sp1 can activate transcription by interacting with the TBP-associated factor TAF II 110, which in turn binds to TAF II 250/TBP (Gill et al., 1994) . In vitro, a minimum complex composed of TAF II 110, TAF II 250, TAF II 150 and TBP is sucient to confer Sp1-mediated transcription (Chen et al., 1994) . We have previously shown that Sp1-mediated transcription is stimulated by Rb (Kim et al., 1992) and repressed by cyclin D1 in cotransfection assays . The repression of Sp1 activity by cyclin D1 was observed in SAOS-2 cells which express a mutant Rb protein, suggesting that cyclin D1 is acting, in part, through an Rb-independent pathway .
TAF II 250, the largest subunit of the TFIID complex, was ®rst identi®ed as the cell cycle control gene, CCG1 (Hisatake et al., 1993; Sekiguchi et al., 1988 Sekiguchi et al., , 1991 . A TAF II 250 temperature-sensitive mutant in the Syrian hamster ts13 cell line induces G1 arrest at the non-permissive temperature (Hayashida et al., 1994; Sekiguchi et al., 1995) , apparently through the aberrant transcriptional regulation of a subset of promoters. In particular, activity of the cyclin A promoter in a transient assay is reduced in ts13 cells at the non-permissive temperature and activity can be restored by coexpression of wild type TAF II 250 (Wang and Tjian, 1994) . The cis-acting element in the cyclin A promoter responsible for conferring the temperature sensitive eect on expression, in addition to the TATA box, has been mapped to an ATF binding site (Wang et al., 1997) . Recent analysis of the yeast TAF II 250 homolog, yTAF II 145, suggests that this may function to regulate transcription of a subset of G1-restricted genes (Walker et al., 1996 (Walker et al., , 1997 . In this regard, we and others have recently demonstrated that cyclin D1 and p21 are dierentially regulated at the transcriptional level in ts13 cells at the non-permissive temperature (Rushton et al., 1997; Suzuki-Yagawa et al., 1997) , consistent with the ability of TAF II 250 to regulate growth regulatory genes. These results suggest that although TAF II 250 is a component of basal transcriptional machinery, it can confer promoterspeci®c regulation in a cell-type dependent manner. Furthermore, TAF II 250 has been shown to have intrinsic serine-threonine kinase activity and histone acetyltransferase activity which also could be important for the regulation of transcription (Dikstein et al., 1996; Mizzen et al., 1996) .
We have shown that Rb associates with TAF II 250/ TFIID and stimulates Sp1-mediated transcription . In this study we investigated the mechanism(s) through which cyclin D1 represses Sp1 activity. Here we show that cyclin D1 represses Sp1-mediated transcription in NIH3T3 cells through the same region that binds to TAF II 110, which in turn interacts with TAF II 250, linking Sp1 to TBP. Repression conferred by D1 is alleviated at the non-permissive temperature in ts13 cells, but is restored by cotransfection with a hTAF II 250 expression vector. We further demonstrate that cyclin D1 interacts with TAF II 250 both in vivo and in vitro. The binding of D1 to TAF II 250 is alleviated by coexpression of either Rb or CDK4 in a dosedependent manner. Taken together, these results suggest that TAF II 250 is an important target for regulation by cyclin D1 and Rb.
Results
Cyclin D1 represses Sp1-mediated transcription through a region in Sp1 that is involved in binding TBP-associated factors
We have previously reported that cyclin D1 represses Sp1-mediated transcription, in part, through an Rbindependent pathway. To identify the pathway(s) through which cyclin D1 represses Sp1, we examined the domains in Sp1 responsible for conferring repression by cyclin D1 using GAL4-Sp1 fusion proteins (Figure 1 ). The use of GAL4-Sp1 fusion proteins, containing dierent transactivation domains of Sp1, allowed for analysis of the eect of cyclin D1 on Sp1-mediated transcription speci®cally, independent of Sp1 DNA binding activity.
NIH3T3 cells were transfected with the indicated pSG4+Sp1 plasmids, which express the GAL4-DNA binding domain (amino acids 1 ± 147) and Sp1 transactivation domains, the G5BCAT reporter, which carries ®ve GAL4 binding sites upstream of the E1B TATA box, and either a human cyclin D1 or Rb expression plasmids. Two days post-transfection, the samples were normalized for transfection eciency and CAT activity was determined. As shown in Figure 1 , cyclin D1 repressed transcription mediated by GAL4-Sp1N (amino acids 83 ± 621) as well as GAL4-SpD (amino acids 262 ± 500), GAL4-Sp1Q (amino acids 339 ± 500) and GAL4-Sp1B-C (amino acids 422 ± 542). In contrast to cyclin D1, Rb stimulated GAL4-Sp1-mediated transcription. The eect on Sp1 was speci®c in that no eect of Rb and only a marginal stimulation by D1 was observed on transcription mediated by GAL4-VP16 (data not shown, see . These results suggest that a region between amino acids 422 and 500, shared between GAL4-Sp1Q and GAL4-Sp1B-C and shown to interact with TAF II 110 (Gill et al., 1994) , is sucient to confer the repression by cyclin D1 and activation by Rb.
To determine if TAF II 250 was important in conferring regulation of Sp1-mediated transcription by D1, similar to Rb, the co-transfection experiments were performed in ts13 cells. ts13 cells are Syrian Hamster Ovary cells that contain a temperaturesensitive mutation in TAF II 250. Similar to previously published observations , Rb was able to stimulate Sp1 transcription in ts13 cells at the permissive temperature (348C) whereas the stimulation was only marginal at the non-permissive temperature (39.68C). In contrast, cyclin D1 marginally repressed cyclin D1 at 348C and marginally stimulated Sp1-mediated transcription at 39.68C (Figure 2a) . However, the ability of D1 to repress transcription was restored by cotransfection of wt human TAF II 250 expression vector in a dose-dependent manner (Figure 2b ). These results suggest that the ability of D1 to repress Sp1-mediated transcription is dependent upon the presence of wt TAF II 250.
Cyclin D1 associates with TAF II 250
We have reported previously that Rb stimulates Sp1 through a similar domain in a TAF II 250-dependent manner and that Rb interacts with TAF II 250 in vitro and in vivo (Shao et al., , 1997 . To test the possibility that D1 regulates Sp1-mediated transcription through an interaction with TAF II 250, the human cyclin D1 and HA-tagged human TAF II 250 (pHAXhTAF II 250) expression plasmids were transfected into C-33A cells, a cervical carcinoma cell line expressing a defective Rb protein. Two days posttransfection, the cells were lysed and aliquots of the cell lysates were immunoprecipitated with antibodies against either cyclin D1 (Figure 3a increasing doses of TAF II 250 plasmid (lanes 6 ± 9). Conversely, cyclin D1 was immunoprecipitated with HA antibody in a dose-dependent manner only when TAF II 250 plasmid was transfected (Figure 3b ). To further demonstrate the association of cyclin D1 with TAF II 250, a coimmunoprecipitation experiment was performed from baculovirus-infected Sf9 insect cells (Figure 3c and d) . Sf9 cells were coinfected with an increasing MOI of cyclin D1 baculovirus and a constant MOI of TAF II 250 baculovirus. Two days post-infection, cell lysates were prepared and incubated with antibodies against either cyclin D1 (Figure 3c ) or HA (Figure 3d ). Immunoprecipitated complexes were analysed by immunoblotting with antibodies against HA ( Figure 3c ) and cyclin D1 (Figure 3d) . A cyclin D1-TAF II 250 complex could be immunoprecipitated with both anti-cyclin D1 and anti-HA antibodies, dependent upon the input dose of the cyclin D1 and TAF II 250 baculoviruses. Taken together, these results demonstrate that cyclin D1 and TAF II 250 associate in both mammalian cells and insect cells coexpressing these proteins.
The amino termini of cyclin D1 and TAF II 250 are sucient to confer the cyclin D1/TAF II 250 interaction To localize the TAF II 250 binding domain in cyclin D1, we tested the ability of certain cyclin D1 mutants to bind to TAF II 250. C-33A cells were transfected with plasmids expressing an HA-tagged TAF II 250 (pHAXhTAF II 250) and either a human full length cyclin D1, D1-mt with an altered LXCXE sequence motif (amino acids 7 ± 8 were mutated and 9 ± 11 deleted) or D1(1 ± 100) containing only the amino terminus of cyclin D1 (amino acids 1 ± 100). Two days post-transfection, aliquots of the cell lysates were incubated with an antibody anti-cyclin D1. Immunoprecipitated complexes were analysed by immunoblotting with antibodies against HA (Figure 4a , top panel) or cyclin D1 (Figure 4a , bottom panel). TAF II 250 was found associated with full length D1 as well as D1(1 ± 100), but not D1-mt. The level of expression of both D1 and D1-mt was similar; however expression of D1(1 ± 100) was reduced. Taken together, these results , and 9 mg of Cyc D1 plasmid. Lanes 6 ± 9, C33-A cells were transfected with Cyc D1 (8 mg) and pHAXhTAF II 250 (1, 3 and 9 mg) plasmids. Fortyeight hours post-transfection, the cells were lysed in 1 ml of EBC buer and the cell lysates (200 ml) analysed by immunoprecipitation/Western blot. The protein extracts were immunoprecipitated with antibody anti-human cyclin D1. The immune complexes were separated by SDS ± PAGE (6% polyacrylamide gel) and subjected to Western blot analysis. The blot was probed with an HA antibody. (b) The cell lysates from the same transfection as in (a) were immunoprecipitated with antibody anti-HA, separated by SDS ± PAGE (12% polyacrylamide gel), and subjected to Western blot analysis. The blot was probed with an antibody anti-human cyclin D1. (c) Sf9 cells were coinfected with TAF II 250 baculovirus, which expresses an HA-tagged human TAF II 250, and Cyc D1 baculovirus, which expresses mouse cyclin D1. Forty-eight hours post-infection, the cells were lysed in 1 ml of EBC buer and immunoprecipitated with an antibody anti-human cyclin D1. The immune complexes were separated by SDS ± PAGE (6% polyacrylamide gel) and subjected to Western blot analysis. The blot was probed with the anti-HA antibody. (d) Same experiment as in (c), but the protein extracts (10 mg) were immunoprecipitated with the anti-HA antibody. The immune complexes were separated by SDS ± PAGE (12% polyacrylamide gel) and subjected to Western blot analysis with an antibody anti-cyclin D1. Lane 4C represents a control where no anti-HA antibody was added to the extract suggest that the TAF II 250 binding domain is localized within the amino terminus of cyclin D1. Preliminary yeast two-hybrid experiments suggested the amino terminus of TAF II 250 was sucient for binding to cyclin D1 (data not shown). Thus, we also tested the ability of cyclin D1 to associate in vitro with a recombinant GST-TAF II 250 (amino acid 1 ± 434). As a control, the binding of GST-Rb (amino acids 379 ± 928) to cyclin D1 was also examined. Protein extracts from Sf9 insect cells infected with the cyclin D1 baculovirus were used as a source of cyclin D1. The proteins bound to glutathione-Sepharose beads were separated by SDS ± PAGE, transferred to a nitrocellulose membrane, and analysed by immunoblotting with (Figure 4b, top panel) . Cyclin D1 bound to GST-TAF II 250 (amino acids 1 ± 434) and GST-Rb (amino acids 379 ± 928) with a similar anity. The level of expression of the GSTfusion proteins was similar as shown by the Coomassie brilliant blue stained gel (Figure 4b, bottom panel) . These results demonstrate that the amino terminus of TAF II 250 is sucient for binding to cyclin D1.
Co-expression of Rb or CDK4 reduces the level of the cyclin D1/TAF II 250 complex
Since Rb can associate with either TAF II 250 or cyclin D1, the eect of Rb protein on the cyclin D1-TAF II 250 complex was examined. Sf9 insect cells were infected with a constant MOI of TAF II 250 and cyclin D1 baculoviruses and an increasing MOI of Rb baculovirus (Figure 5a ). Two days post-infection, cell lysates were prepared and used for immunoprecipitation with an antibody anti-cyclin D1. The immune complexes bound to protein A-Sepharose beads were separated by SDS ± PAGE, transferred to a nitrocellulose membrane and analysed by immunoblotting with an antibody anti-HA (Figure 5a, top panel) . An aliquot of each lysate was analysed by immunoblotting with HA antibody to determine the level of expression of TAF II 250 (Figure 5a, bottom panel) . The expression of Rb resulted in a decrease in the level of cyclin D1-TAF II 250 complex in a dose-dependent manner.
The eect of CDK4 on the cyclin D1-TAF II 250 complex, in a similar experiment as with Rb, was examined using baculovirus expressing mouse CDK4. As was observed with Rb, the expression of CDK4 reduced the level of cyclin D1-TAF II 250 complex in a dose-dependent manner (Figure 5b, top panel) . This result suggests that CDK4 may be reducing the level of the cyclin D1-TAF II 250 complex by binding to cyclin D1.
Regulation of Sp1-mediated transcription by cyclin D1 mutants
The results presented in Figure 4 show that the TAF II 250-binding domain is localized at the amino terminus of cyclin D1, overlapping with the Rb binding domain. To determine whether the repression of Sp1-mediated transcription correlates with the binding of cyclin D1 to TAF II 250, we tested the ability of cyclin D1 mutants to repress Sp1. NIH3T3 cells were transfected with pSG+Sp1N and either D1, D1-mt or D1(1 ± 100) ( Figure 6 ). Two days post-transfection, the samples were normalized for transfection eciency and CAT activity determined. D1 wild type as well as D1(1 ± 100) repressed Sp1-mediated transcription, while D1-mt was unable to repress Sp1. Furthermore, as shown in Figure 4 , only D1 and D1(1 ± 100) bind to TAF II 250, but D1-mt does not. Thus, it seems that the binding to TAF II 250 correlates with the ability of cyclin D1 to repress Sp1. 
Discussion
We have previously shown that Sp1-mediated transcription is stimulated by Rb and repressed by cyclin D1 (Kim et al., 1992; . The stimulation of Sp1-mediated transcription by Rb occurs, in part, through a TAF II 250-dependent pathway . Moreover, Rb is able to bind directly to TAF II 250 . In this study, we investigated the mechanism(s) through which cyclin D1 regulates Sp1 transcriptional activity. Although cyclin D1 may aect Sp1-mediated transcription through direct phosphorylation of Rb, it also can work through an Rb-independent pathway. We identi®ed a region in Sp1 (amino acids 422 ± 500) which appears sucient to confer repression by cyclin D1 and stimulation by Rb. This region of Sp1 is able to interact with TAF II 110, which in turn binds to TAF II 250/TBP (Gill et al., 1994) . Furthermore, we found that TAF II 250 associated with cyclin D1 in immunoprecipitation assays and in vitro using a recombinant GST-TAF II 250 (amino acids 1 ± 434).
A domain in cyclin D1 important for both binding TAF II 250 and for repressing Sp1-mediated transcription was found within the ®rst 100 amino acids of D1. Moreover, a deletion in the amino terminus of cyclin D1 extending into the Rb binding domain decreased the anity of cyclin D1 for TAF II 250 and in its ability to repress Sp1-mediated transcription. However, a two amino acid change within the LXCXE Rb-binding motif, which abolishes cyclin D-binding to Rb, still repressed Sp1 mediated transcription and bound with intermediate anity to TAF II 250 (data not shown). Thus the Rb binding and the TAF II 250 binding/Sp1 regulatory domain in cyclin D1 appear to be overlapping. It is important to note that additional domains in cyclin D1 may be important for conferring either binding or Sp1-mediated repression in that the D1 (1 ± 100) mutant was not as eective as wild-type. In addition, it is possible that D1 is able to repress transcription conferred by Sp1 through multiple pathways.
We also have shown that the ®rst 434 amino acids in TAF II 250 are capable of binding cyclin D1 in vitro. Preliminary analysis using a baculovirus-expressed GST-D1 fusion protein in vitro suggests that D1 can bind to a region between amino acids 200 ± 434. This region of TAF II 250 was shown to contain a novel serine/threonine kinase activity able to phosphorylate RAP74 (TFIIF) and the co-activator PC4 as well as phosphorylate itself (Dikstein et al., 1996; Ruppert and Tjian, 1995; Malik et al., 1998) . This same region of TAF II 250 also was capable of binding to the large pocket of Rb (Shao and Robbins, 1997) . Since both Rb and cyclin D1 bind to a same region in TAF II 250, we examined the eect of Rb co-expression on the level of the cyclin D1-TAF II 250 complex. In Sf9 insect cells, coexpression of Rb reduced the level of the cyclin D1-TAF II 250 complex in a dose-dependent manner. However, it is not clear whether Rb is blocking the TAF II 250/D1 interaction by binding to cyclin D1 or by competing for binding to TAF II 250.
Although cyclin D1 binds to TAF II 250, we have not observed phosphorylation of TAF II 250 by cyclin D1/ CDK4. In fact, co-expression of CDK4 prevented the formation of the cyclin D1-TAF II 250 complex in Sf9 cells. The ability of CDK4 to inhibit the formation of D1/TAF II 250 complex, but not D1(1 ± 100)/TAF II 250 complex (data not shown) suggests that the binding of CDK4 to cyclin D1 may prevent interaction with TAF II 250. Consistent with the observation that CDK4 abolishes binding of D1 to TAF II 250, CDK4 is able to stimulate Sp1-mediated transcription in a cotransfection assay and partially overcomes repression conferred by D1. It is likely that the binding of cyclin D1 to TAF II 250 aects TAF II 250 function without targeting the CDK4 kinase to TAF II 250. However, it is still possible that the binding of cyclin D1 to TAF II 250 targets CDK4 to the basal transcription complex, resulting in the phosphorylation of speci®c targets and release of cyclin D1 from TAF II 250.
The stimulation and repression of Sp1-mediated transcription by Rb and cyclin D1, respectively, is reminiscent of the regulation of MyoD. Rb has been shown to be required for stimulation of MyoDmediated transcription and for myoblast differentiation (Gu et al., 1993) . Conversely, cyclin D1 is able to reverse this transcriptional stimulation and differentiation without binding to Rb and, apparently, without promoting the phosphorylation of Rb (Skapek et al., 1996) . These results suggest that Rb and cyclin D1 may target a similar factor for conferring the dierential eects on transcription and dierentiation. However, there is no evidence yet implicating TAF II 250 in the regulation of muscle speci®c gene expression or dierentiation.
Recently cyclin D1 has been shown to directly regulate transcription, independent of CDK4, by directly associating with the estrogen receptor. D1 was found associated with the DNA-bound estrogen receptor, enhancing both the basal and estrogeninduced activity. This observation suggests that D1 plays an important role in regulating the estrogen response, especially in mammary tissue. Since TAF II 250 has been shown to play a role in the regulation of expression of speci®c genes, it may be serving as a target similar to the estrogen receptor, to regulate a subset of genes in speci®c cells types. It is of interest that transcription of the D1 gene itself is reduced in ts13 cells at the non-permissive temperature whereas p21 expression is stimulated. Whether the association of D1 or Rb with TAF II 250 is important for regulation of D1 and p21 transcription is under investigation.
How does D1 and Rb regulate transcription through TAF II 250? We recently have shown that Rb is able to inhibit the TAF II 250 amino terminal kinase activity in vitro through association with the amino terminus of TAF II 250 (Siegert and Robbins, 1998) . Indeed, Rb is able both TAF II 250 autophosphorylation as well as phosphorylation of RAP74. In preliminary experiments, cyclin D1 is able to block Rb-mediated inhibition of TAF II 250 kinase activity in vitro. Thus cyclin D1 may regulate transcription through the regulation of the amino terminal kinase activity of TAF II 250. Alternatively, cyclin D1 may be able to regulate the histone acetyltransferase activity of TAF II 250 or potentially other unidenti®ed activities of TAF II 250.
The binding of Rb and cyclin D1 to TAF II 250 appears to be important for the regulation of transcription mediated by Sp1 and potentially other transcription. By competing for binding to TAF II 250, alterations in the level and/or activity of Rb or cyclin D1 could lead to either activation or repression of cell growth regulatory genes (Figure 7) . At a high level of Rb, the association of cyclin D1 with TAF II 250 is inhibited and the formation of the TAF II 250/Rb complex could be favored. Based on this model, the interaction of Rb with TAF II 250 would result then in the stimulation of Sp1-mediated transcription. Conversely, at a high level of D1, the interaction of Rb with TAF II 250 might be reduced and the formation of the TAF II 250/D1 complex favored, resulting in the repression of Sp1-mediated transcription. It has been demonstrated that TAF II 250 is important for G1 phase progression of the cell cycle and can regulate the activity of speci®c cell cycle regulated promoters in either a positive or negative manner (Rushton et al., 1997; Wang and Tjian, 1994; Suzuki-Yagawa et al., 1997) . Thus, the interactions of TAF II 250 with cyclin D1 and Rb appear to be important in mediating cell cycle control.
Materials and methods

Constructs
pSG4+Sp1N,
pSG4+Sp1Q, pSG4+Sp1D and pSG4+Sp1B-C, which express the Gal4-DNA binding domain and Sp1 trans-activation domains, were kindly provided by G Gill (Gill et al., 1994) . pSG147 expresses the Gal4-DNA binding domain alone and G5BCAT is a CAT reporter having ®ve Gal4 binding sites. The D1 plasmid, which expresses human wild type cyclin D1, was constructed by inserting the EcoRI cDNA insert from pPL-8 provided by A Arnold (Motokura et al., 1991) into the EcoRT site of the SVE plasmid, an SV40 early promoter-based expression vector. To construct D1(1 ± 100), the D1 plasmid was digested with PstI and KpnI, the ends ®lled in, and the 4.1 Kb insert ligated to a STOP-XhoI linker. In the D1-mt plasmid, the LXCXE sequence motif (LLCCE in cyclin D1, amino acids 5 ± 9) was altered to LLSS, accomplished by mutating nucleotide 206T?A and nucleotide 210G?C, which created a new SacI site . Additionally, amino acids 9 ± 11 were deleted by PCR ampli®cation of human cyclin D1 cDNA using a 5' oligonucleotide carrying a SacI site followed by the nucleotide sequence encoding amino acids 12 ± 17. The PCR product was digested with SacI and ligated to the SacI site that was created by the two nucleotide mutations described above. The cyclin D1 and CDK4 baculoviruses were kindly provided by C Sherr and express mouse cyclin D1 and CDK4, respectively. TAF II 250 baculovirus and pHAXhTAF II 250 were provided by S Ruppert and express human full length TAF II 250 . GST-TAF II 250 (amino acids 1 ± 434) was provided by S Ruppert and GST-Rb (amino acids 379 ± 928) was kindly provided by W Kaelin. The Rb baculovirus was previously described (Chen et al., 1995) .
Cell culture, transfections and CAT assays C-33A, ts13 and NIH3T3 cell lines were grown in Dulbecco's modi®ed Eagle medium (GIBCO/BRL) supplemented with 10% fetal bovine serum. Spodoptera frugiperda (Sf9) cells were cultured at 278C in Grace's medium supplemented with 10% fetal calf serum, yeastolate, lactalbumin hydrolysate, and gentamicin. C-33A, ts13 and NIH3T3 cells were transfected at 40% con¯uence, using the calcium phosphate precipitation method as described previously (Adnane et al., 1995) . DNA precipitates were removed 15 h after transfection, and the cells were replenished with fresh medium. Cells were harvested 30 h later, and chloramphenicol acetyltransferase (CAT) activity was determined. One microgram of SV40-luciferase plasmid was also transfected to monitor transfection eciency. All transfections were repeated a minimum of three times, and the standard deviations were calculated.
Immunoprecipitation and Western blot analysis
For production of lysates containing recombinants proteins, 1610 6 Sf9 cells were infected, lysed 48 h postinfection with 1 ml of EBC buer (50 mM Tris-HCl, pH 8.0; 120 mM NaCl; 0.5% Nonidet P-40) containing 5 mg/ml phenylmethylsulfonyl¯uoride, leupeptin, and aprotinin, 0.1 mM sodium¯uoride, 10 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 1 mM EDTA and 1 mM dithiothreitol, and used for immunoprecipitation and binding assays. Cells extract from C-33A cells was prepared as described above. For the immunoprecipitations, the cell lysates were incubated with either an HA polyclonal antibody (Berkely Antibody Company) (1 : 1000 dilution) or cyclin D1 polyclonal antibody (Santa Cruz Biotechnology) (1 : 500 dilution) for 2 h at 48C, followed by addition of 20 ml of protein A-Sepharose (1 : 1) for 1 h at 48C. The immune complexes bound to protein A-Sepharose beads were washed ®ve times with 1 ml of EBC buer, separated by SDS ± PAGE and transferred to nitrocellulose membranes. The membranes were blocked by incubation in 0.2% Tween-20 in phosphate-buered saline (PBS-T) containing 5% dry milk, for 1 h at room temperature. The membranes were then incubated with either an HA monoclonal antibody (12CA5) or a cyclin D1 monoclonal antibody (Santa Cruz Biotechnology) diluted in PBS-T containing 1% dry milk, for 2 h at room temperature. Goat anti-mouse Ig G-peroxidase conjugate (1 : 5000 dilution) was used as the secondary antibody, followed by ECL (Enhanced Chemi-Luminescence, Amersham) detection.
Protein binding assay
Glutathione S-transferase (pGEX-2T, Pharmacia) plasmids encoding GST-Rb (amino acids 379 ± 928) and GST-TAF II 250 (amino acids 1 ± 434) fusion proteins were introduced into Escherichia coli strain DH5a, and bacterial cultures, grown overnight in LB broth containing ampicillin, were diluted 1 : 10 in 100 ml of fresh broth and grow for 90 min at 378C. Exponentially growing cells were induced to express the fusion proteins with isopropyl-b-Dthiogalactopyranoside (IPTG) for 2.5 h, pelleted at 48C, suspended in 5 ml of TNEN buer (20 mM tris-HCl, pH 8.0; 150 mM NaCl; 1 mM EDTA; 0.5% Nonidet P-40), and lysed by sonication. After centrifugation to remove debris, lysate was diluted with 1 vol of TNEN buer and divided into 1 ml aliquots. Glutathione-Sepharose beads (1.0 ml; Pharmacia) were washed three times in 5 ml of TNEN containing 40 mg/ml bovine serum albumin and suspended in an equal volume of the same buer. Washed beads (30 ml) were added to each lysate aliquot and rotated for 30 min at 48C. The beads were then washed three times with low salt TNEN (TNEN containing 100 mM NaCl) and suspended in an equal volume of buer. 0.25 ml of insect cell lysate containing cyclin D1 (*5 mg) was combined with 30 ml of GST-Rb (*2 mg) or GST-TAF II 250 (*2 mg) glutathione-Sepharose beads and incubated at 258C for 1 h with occasional mixing. The beads were washed ®ve times with low salt TNEN and bound proteins eluted by boiling in 16Laemmli buer, separated by SDS ± PAGE (12% polyacrylamide), and transferred to nitrocellulose membranes. The immunoblot analysis was performed as described above.
